Eventide Healthcare & Life Sciences Fund (ETAHX) is an MF managed by Independent / Boutique. Its largest position is Guardant Health, Inc. (GH), representing 4.07% of fund assets.
Eventide Healthcare & Life Sciences Fund Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- ETAHX
- Type:
- MF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 29, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
Guardant Health, Inc.
|
4.07% | $64,688,650.77 | 700,321 |
|
-
Mirum Pharmaceuticals, Inc.
|
4.02% | $63,820,353.48 | 690,846 |
|
-
INSMED Inc
|
3.78% | $60,041,764.16 | 367,183 |
|
-
APPLIED MATERIALS INC /DE
|
3.65% | $57,967,292.82 | 57,967,293 |
|
-
BELITE BIO, INC
|
3.30% | $52,395,810.56 | 328,624 |
|
-
Kymera Therapeutics, Inc.
|
3.28% | $52,139,540.00 | 626,000 |
|
-
Vaxcyte, Inc.
|
3.03% | $48,087,245.31 | 827,521 |
|
-
APOGEE THERAPEUTICS INC
|
2.96% | $46,918,293.91 | 557,423 |
|
-
IONIS PHARMACEUTICALS INC
|
2.72% | $43,176,750.00 | 575,000 |
|
-
ARGENX SE
|
2.26% | $35,923,188.25 | 49,193 |
|
-
Abivax S.A.
|
2.25% | $35,666,629.85 | 320,311 |
|
-
Scholar Rock Holding Corp
|
2.23% | $35,336,552.12 | 718,807 |
|
-
Celldex Therapeutics, Inc.
|
2.07% | $32,893,640.00 | 1,037,000 |
|
-
iRhythm Holdings, Inc.
|
2.06% | $32,778,756.78 | 277,739 |
|
-
BridgeBio Pharma, Inc.
|
2.04% | $32,461,273.80 | 437,130 |
|
-
CYTOKINETICS INC
|
1.99% | $31,572,735.48 | 479,028 |
|
-
Trevi Therapeutics, Inc.
|
1.97% | $31,284,110.58 | 2,622,306 |
|
-
PALVELLA THERAPEUTICS, INC.
|
1.82% | $28,854,480.60 | 231,484 |
|
-
Celcuity Inc.
|
1.75% | $27,721,524.22 | 242,873 |
|
-
KESTRA MEDICAL TECHNOLOGIES, LTD.
|
1.72% | $27,266,950.48 | 1,368,136 |
|
-
Axsome Therapeutics, Inc.
|
1.69% | $26,899,702.02 | 159,151 |
|
-
MBX Biosciences, Inc.
|
1.67% | $26,566,500.00 | 890,000 |
|
-
CENTESSA PHARMACEUTICALS PLC
|
1.67% | $26,538,600.24 | 668,142 |
|
-
Sionna Therapeutics, Inc.
|
1.63% | $25,838,967.16 | 644,524 |
|
-
Disc Medicine, Inc.
|
1.59% | $25,271,325.90 | 395,235 |
|
-
FIRST AMERICAN GOVERNMENT OBLI
|
1.58% | $25,052,032.63 | 25,052,033 |
|
-
Revolution Medicines, Inc.
|
1.58% | $25,014,450.50 | 257,218 |
|
-
CG Oncology, Inc.
|
1.56% | $24,797,748.96 | 366,397 |
|
-
Immix Biopharma, Inc.
|
1.46% | $23,221,563.09 | 2,549,019 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
1.46% | $23,199,000.00 | 370,000 |
|
-
Evommune, Inc.
|
1.36% | $21,613,335.81 | 940,119 |
|
-
ADC Therapeutics SA
|
1.35% | $21,381,206.25 | 5,701,655 |
|
-
Amylyx Pharmaceuticals, Inc.
|
1.32% | $21,022,971.60 | 1,512,444 |
|
-
Beta Bionics, Inc.
|
1.30% | $20,562,803.52 | 2,052,176 |
|
-
Nurix Therapeutics, Inc.
|
1.27% | $20,117,341.50 | 1,297,893 |
|
-
Dianthus Therapeutics, Inc. /DE/
|
1.19% | $18,903,903.12 | 225,261 |
|
-
SUTRO BIOPHARMA, INC.
|
1.12% | $17,818,297.37 | 715,307 |
|
-
Heartflow, Inc.
|
1.09% | $17,380,646.43 | 714,371 |
|
-
UNITED THERAPEUTICS Corp
|
1.05% | $16,747,534.14 | 28,243 |
|
-
Avalyn Pharma Inc.
|
1.03% | $16,310,046.73 | 20,482,289 |
|
-
EyePoint, Inc.
|
1.01% | $16,055,564.87 | 1,245,583 |
|
-
DEXCOM INC
|
1.00% | $15,863,970.80 | 252,611 |
|
-
GeneDx Holdings Corp.
|
0.98% | $15,614,707.68 | 243,144 |
|
-
Ovid Therapeutics Inc.
|
0.98% | $15,587,325.96 | 7,021,318 |
|
-
GLAUKOS Corp
|
0.97% | $15,362,220.72 | 142,692 |
|
-
Privia Health Group, Inc.
|
0.96% | $15,174,365.58 | 737,694 |
|
-
Definium Therapeutics, Inc.
|
0.82% | $12,968,461.80 | 686,162 |
|
-
Praxis Precision Medicines, Inc.
|
0.78% | $12,342,132.33 | 38,307 |
|
-
Oric Pharmaceuticals, Inc.
|
0.76% | $12,054,656.11 | 951,433 |
|
-
Invivyd, Inc.
|
0.74% | $11,793,593.50 | 9,071,995 |
Advertisement (320x50)